BML Investment Holds 2.5% of Oramed (ORMP) in Amended 13G/A

Rhea-AI Filing Summary

Oramed Pharmaceuticals Inc. reports amended Schedule 13G/A ownership by BML Investment Partners, L.P. The filing states BML Investment Partners, L.P. beneficially owns 1,026,269 shares of Common Stock, representing 2.5% of the class. The filing attributes shared voting and dispositive power of 866,269 shares and sole power over 160,000 shares.

The filing explains that BML Capital Management, LLC is the general partner and that Braden M. Leonard is the managing member and deemed indirect owner; the reporting persons disclaim being a statutory group under Rule 13d-5(b)(1).

Insights

Corporate Governance Analyst

Beneficial ownership disclosure confirms a sub-5% stake with indirect ownership structure.

The Schedule 13G/A shows 1,026,269 shares (2.5%) beneficially owned by BML Investment Partners, L.P., with 866,269 shares held with shared voting/dispositive power and 160,000 shares under sole power. This clarifies the reporting chain through BML Capital Management, LLC and Mr. Leonard.

Filing is routine disclosure under beneficial ownership rules; subsequent filings would update position size or group status if changed.

Securities Compliance Specialist

Amendment emphasizes attribution and Rule 13d-5(b)(1) disclaimer.

The amendment restates ownership and provides a specific attribution narrative: BML Investment Partners, L.P. (Delaware) holds the shares and the general partner and managing member relationships create indirect attribution to Braden M. Leonard.

Compliance-wise, the filing documents beneficial ownership and the disclaimer about statutory group status; any future change in voting arrangements would require updated disclosure.

Key Figures

Beneficial ownership: 1,026,269 shares Percent of class: 2.5% Shared voting/dispositive power: 866,269 shares +2 more

5 metrics

Beneficial ownership 1,026,269 shares reported beneficially owned

Percent of class 2.5% percent of common stock

Shared voting/dispositive power 866,269 shares shared power reported

Sole voting/dispositive power 160,000 shares sole power reported

Filing signature date 06/29/2026 signature date on amendment

Key Terms

Schedule 13G/A, beneficially owned, shared dispositive power, statutory group

4 terms

Schedule 13G/A regulatory

"Amendment No. 3; BML Investment Partners, L.P. files Schedule 13G/A"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

beneficially owned market

"Amount beneficially owned: 1026269"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

shared dispositive power regulatory

"Shared Dispositive Power 866,269.00"

statutory group regulatory

"disclaim that they constitute a statutory group within the meaning of Rule 13d-5(b)(1)"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 06/29/2026 - 10:34 AM Accepted by SEC EDGAR 06/29/2026 - 10:33 AM Learn about SEC filing dates

FAQ

What stake does BML Investment Partners hold in ORMP?

BML Investment Partners reports beneficial ownership of 1,026,269 shares, equal to 2.5% of ORMP. The filing lists 866,269 shares with shared voting/dispositive power and 160,000 shares with sole voting/dispositive power.

Who is attributed as the indirect owner in the Schedule 13G/A for ORMP?

Braden M. Leonard is deemed the indirect owner through BML Capital Management, LLC. The filing explains that BML Capital Management, LLC is the general partner of BML Investment Partners, L.P., and Mr. Leonard is the managing member.

Does the filing indicate a statutory group for ORMP holdings?

No — the reporting persons expressly disclaim constituting a statutory group under Rule 13d-5(b)(1). The amendment repeats that despite shared beneficial ownership, they do not claim group status in the filing.

What voting and dispositive powers are reported for ORMP shares?

The filing reports sole voting/dispositive power over 160,000 shares and shared voting/dispositive power over 866,269 shares. Those counts sum to a total beneficial ownership of 1,026,269 shares, or 2.5% of the class.

When was the amended Schedule 13G/A signed for ORMP?

The filing signatures are dated 06/29/2026 by Braden M. Leonard and Leonard Braden Michael. The amendment header also shows an internal date of 06/26/2026 alongside the CUSIP reference for the Common Stock class.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 3)

ORAMED PHARMACEUTICALS INC.

(Name of Issuer)

Common Stock par value $0.012 per share

(Title of Class of Securities)

68403P203

(CUSIP Number)

06/26/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 68403P203

1

Names of Reporting Persons

BML Investment Partners, L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 866,269.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 866,269.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

866,269.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

2.1 %

12

Type of Reporting Person (See Instructions)

PN

SCHEDULE 13G

CUSIP Number(s): 68403P203

1

Names of Reporting Persons

Leonard Braden Michael

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 160,000.00
6	Shared Voting Power 866,269.00
7	Sole Dispositive Power 160,000.00
8	Shared Dispositive Power 866,269.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,026,269.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

2.5 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: BML Investment Partners, L.P. is a Delaware limited partnership whose sole general partner is BML Capital Management, LLC. The managing member of BML Capital Management, LLC is Braden M. Leonard. As a result, Braden M. Leonard is deemed to be the indirect owner of the shares held directly by BML Investment Partners, L.P. Despite such shared beneficial ownership, the reporting persons disclaim that they constitute a statutory group within the meaning of Rule 13d-5(b) (1) of the Securities Exchange Act of 1934

SCHEDULE 13G

Item 1.
(a)	Name of issuer: ORAMED PHARMACEUTICALS INC.
(b)	Address of issuer's principal executive offices: 1185 Avenue of the Americas, Third Floo, New York, New York, 10036
Item 2.
(a)	Name of person filing: BML Investment Partners, L.P
(b)	Address or principal business office or, if none, residence: 65 E Cedar, Suite 2 Zionsville, IN 46077
(c)	Citizenship: Delaware
(d)	Title of class of securities: Common Stock par value $0.012 per share
(e)	CUSIP No.: 68403P203
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 1026269
(b)	Percent of class: 2.5 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 160000
	(ii) Shared power to vote or to direct the vote: 866269
	(iii) Sole power to dispose or to direct the disposition of: 160000
	(iv) Shared power to dispose or to direct the disposition of: 866269
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

BML Investment Partners, L.P.

Signature:	Braden M Leonard
Name/Title:	BML Capital Management, LLC its General Partner By: Braden M Leonard, its Managing Member
Date:	06/29/2026

Leonard Braden Michael

Signature:	Braden M Leonard
Name/Title:	Leonard Braden Michael
Date:	06/29/2026

Comments accompanying signature: BML Investment Partners, L.P. is a Delaware limited partnership whose sole general partner is BML Capital Management, LLC. The managing member of BML Capital Management, LLC is Braden M. Leonard. As a result, Braden M. Leonard is deemed to be the indirect owner of the shares held directly by BML Investment Partners, L.P. Despite such shared beneficial ownership, the reporting persons disclaim that they constitute a statutory group within the meaning of Rule 13d-5(b)(1) of the Exchange Act.